Why did MMEN.CN jump 33.33% today?

The jump to C$0.02 on 02 Jan 2026 was driven by higher intraday volume (189,038) versus average (145,639), creating short-term buying momentum. No single confirmed catalyst was identified in public filings; volume-driven moves are common in small-cap cannabis stocks.

What are the main financial risks for MedMen Enterprises Inc.?

Primary risks include negative EPS (-0.15), a low current ratio (0.49), high debt-to-equity (2.61), and negative operating cash flow per share (-0.05). These metrics point to potential liquidity pressure and the need for capital or improved operations.

What price target does Meyka AI give for MMEN.CN?

Meyka AI's forecast model projects a 12-month base target of C$0.05 versus the current C$0.02 (implied upside 150.00%). A conservative target is C$0.03 (implied upside 50.00%). Forecasts are model-based and not guarantees.

Is MMEN.CN a buy for long-term investors?

Meyka AI assigns a B grade with suggestion HOLD. Long-term buying requires clear earnings improvement, cash-flow recovery, or a credible capital plan. Given current fundamentals and leverage, many investors may wait for operational signs of stabilization.

CA Stocks

MMEN.CN up 33.33% to C$0.02 on 02 Jan 2026: volume-backed rally warrants close monitoring

ByDanny Kontos January 3, 2026January 3, 2026

MedMen Enterprises Inc. (MMEN.CN) jumped 33.33% to C$0.02 in Canada (CNQ) during market hours on 02 Jan 2026, driven by a volume surge to 189,038 shares versus an average 145,639. The MMEN.CN stock move is notable for its size relative to the float and comes after a prior low of C$0.015 today and a 12-month high of C$0.05. This article breaks down intraday momentum, balance-sheet signals, valuation metrics, and where Meyka AI’s model sees 12-month potential, with actionable context for traders and longer-term investors.